Who is to say what is happening with the A/S or O/S right now? It has taken much less volume (less than quarter) to raise the PPS this time as it did in September. When debt is all paid (if not already paid) the dilution will stop (if it hasn't already) and should keep going up.
Also, umbilical and placenta (cord blood) stem cell research is vastly growing and attracting many researchers and financial interests. Who is to say deals and businesses aren't already getting involved with CBAI? Or that legislation isn't making cord blood a more attractive alternative to controversial emrbyonic stem cells?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.